Naxitamab Interactions
There are 317 drugs known to interact with naxitamab, along with 1 disease interaction, and 1 alcohol/food interaction. Of the total drug interactions, 48 are major, and 268 are moderate.
- View all 317 medications that may interact with naxitamab
- View naxitamab alcohol/food interactions (1)
- View naxitamab disease interactions (1)
Most frequently checked interactions
View interaction reports for naxitamab and the medicines listed below.
- Advair Diskus (fluticasone / salmeterol)
- Amitiza (lubiprostone)
- Anoro Ellipta (umeclidinium / vilanterol)
- Aspirin Low Strength (aspirin)
- Benadryl (diphenhydramine)
- Bentyl (dicyclomine)
- Breo Ellipta (fluticasone / vilanterol)
- Coricidin HBP Cold & Flu (acetaminophen / chlorpheniramine)
- Coricidin HBP Cough & Cold (chlorpheniramine / dextromethorphan)
- Flonase (fluticasone nasal)
- Flovent HFA (fluticasone)
- Fluarix Quadrivalent (influenza virus vaccine, inactivated)
- IBU (ibuprofen)
- Iron Sulfate (ferrous sulfate)
- MiraLAX (polyethylene glycol 3350)
- Mucinex (guaifenesin)
- Mucinex DM (dextromethorphan / guaifenesin)
- Ozempic (semaglutide)
- Pepcid AC (famotidine)
- Percocet (acetaminophen / oxycodone)
- Prilosec OTC (omeprazole)
- ProAir HFA (albuterol)
- Qvar RediHaler (beclomethasone)
- Rocephin (ceftriaxone)
- Singulair (montelukast)
- Sprycel (dasatinib)
- Symbicort (budesonide / formoterol)
- Tasigna (nilotinib)
- Tradjenta (linagliptin)
- Trelegy Ellipta (fluticasone / umeclidinium / vilanterol)
Naxitamab alcohol/food interactions
There is 1 alcohol/food interaction with naxitamab.
Naxitamab disease interactions
There is 1 disease interaction with naxitamab which include:
Report options
QR code containing a link to this page
More about naxitamab
- naxitamab consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
